Media

Thetford Mines, Quebec – June 28, 2023 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces the voting results of the annual general and special meeting of shareholders (the “Meeting”) held yesterday, in Longueuil.

Thetford Mines, Quebec – May 29, 2023 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that on May 26, 2023, after market hours, the Corporation has entered into a share purchase agreement (the “Share Purchase Agreement”) with 9486-4410 Quebec Inc. (the “Purchaser”), a subsidiary of U.S.-based Clinical Education Alliance, LLC, pursuant to which the Purchaser has agreed to acquire, subject to the fulfilment of certain conditions, all the shares of Agence L.I.V. Inc. (“LIV”), a wholly-owned subsidiary of KDA, for an aggregate purchase price of thirteen million five hundred thousand dollars ($13,500,000) (the “Sale Price”).

KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the restructuring, as of May 4, 2023, of its total debt owed to Persistence Capital Partners II, L.P. and Persistence Capital Partners II (International), L.P., (collectively “PCP”).

Thetford Mines, Quebec – May 4, 2023 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the completion of the transactions with 9483-0296 Quebec Inc. (“9483”) and Groupe Sante Halsa Inc (“Halsa”), previously announced by press release dated March 27, 2023, according to which 9483 and Halsa (collectively the “Buyer”) acquired the business of placement agency for pharmacists and pharmacy technical assistants for a total consideration of ten million two hundred thousand dollars (CAN $10,200,000). The transactions are effective as of May 1, 2023.

Thetford Mines, Quebec – March 27, 2023 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the Corporation has entered into an asset purchase agreement (the “Asset Purchase Agreement”) with 9483-0296 Québec Inc. (“9483”) and a share purchase agreement (the “Share Purchase Agreement”) with Halsa Health Group Inc. (“Halsa”) pursuant to which 9483 and Halsa, affiliated companies (collectively the “Buyer”), have agreed to acquire, subject to the fulfilment of certain conditions, KDA’s pharmacist and pharmacy technical assistant placement agency business for a total consideration of ten million two hundred thousand dollars ($10,200,000) (the “Sale Price”).